Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980–2004
- 1 December 2005
- journal article
- research article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 5 (12), 763-774
- https://doi.org/10.1016/s1473-3099(05)70296-6
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agendaThe Lancet Infectious Diseases, 2002
- Drug resistance in Indian visceral leishmaniasisTropical Medicine & International Health, 2001
- Failure of Pentavalent Antimony in Visceral Leishmaniasis in India: Report from the Center of the Indian EpidemicClinical Infectious Diseases, 2000
- Socio-economics of visceral leishmaniasis in Bihar (India)Transactions of the Royal Society of Tropical Medicine and Hygiene, 2000
- Treatment of visceral leishmaniasis (kala-azar): A decade of progress and future approachesInternational Journal of Infectious Diseases, 2000
- Calculating the number needed to treat for trials where the outcome is time to an eventBMJ, 1999
- LeishmaniasisThe Lancet, 1999
- Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India Commentary: Some good news for treatment of visceral leishmaniasis in BiharBMJ, 1998
- Practical guide for the treatment of leishmaniasis.Drugs, 1998
- The number needed to treat: a clinically useful nomogram in its proper contextBMJ, 1996